130 related articles for article (PubMed ID: 34100239)
1. Temporal Patterns of High-Spend Subgroups Can Inform Service Strategy for Medicare Advantage Enrollees.
Amodeo SJ; Kowalkowski HF; Brantley HL; Jones NW; Bangerter LR; Cook DJ
J Gen Intern Med; 2022 Jun; 37(8):1853-1861. PubMed ID: 34100239
[TBL] [Abstract][Full Text] [Related]
2. Contribution of preventable acute care spending to total spending for high-cost Medicare patients.
Joynt KE; Gawande AA; Orav EJ; Jha AK
JAMA; 2013 Jun; 309(24):2572-8. PubMed ID: 23797716
[TBL] [Abstract][Full Text] [Related]
3. Geographic Variation in Medicare Fee-for-Service Health Care Expenditures Before and After the Passage of the Affordable Care Act.
Sood N; Yang Z; Huckfeldt P; Escarce J; Popescu I; Nuckols T
JAMA Health Forum; 2021 Dec; 2(12):e214122. PubMed ID: 35977300
[TBL] [Abstract][Full Text] [Related]
4. Subgroups of High-Cost Medicare Advantage Patients: an Observational Study.
Powers BW; Yan J; Zhu J; Linn KA; Jain SH; Kowalski JL; Navathe AS
J Gen Intern Med; 2019 Feb; 34(2):218-225. PubMed ID: 30511290
[TBL] [Abstract][Full Text] [Related]
5. Identifying Patients with Persistent Preventable Utilization Offers an Opportunity to Reduce Unnecessary Spending.
Zhang Y; Khullar D; Wu Y; Casalino LP; Kaushal R
J Gen Intern Med; 2020 Dec; 35(12):3534-3541. PubMed ID: 32720238
[TBL] [Abstract][Full Text] [Related]
6. Persistent high utilization in a privately insured population.
Hwang W; LaClair M; Camacho F; Paz H
Am J Manag Care; 2015 Apr; 21(4):309-16. PubMed ID: 26014469
[TBL] [Abstract][Full Text] [Related]
7. High-Cost Patients: Hot-Spotters Don't Explain the Half of It.
Lee NS; Whitman N; Vakharia N; Taksler GB; Rothberg MB
J Gen Intern Med; 2017 Jan; 32(1):28-34. PubMed ID: 27480529
[TBL] [Abstract][Full Text] [Related]
8. Analysis of Drivers of Disenrollment and Plan Switching Among Medicare Advantage Beneficiaries.
Meyers DJ; Belanger E; Joyce N; McHugh J; Rahman M; Mor V
JAMA Intern Med; 2019 Apr; 179(4):524-532. PubMed ID: 30801625
[TBL] [Abstract][Full Text] [Related]
9. Service use at the end-of-life in Medicare advantage versus traditional Medicare.
Stevenson DG; Ayanian JZ; Zaslavsky AM; Newhouse JP; Landon BE
Med Care; 2013 Oct; 51(10):931-7. PubMed ID: 23969590
[TBL] [Abstract][Full Text] [Related]
10. Comparing post-acute rehabilitation use, length of stay, and outcomes experienced by Medicare fee-for-service and Medicare Advantage beneficiaries with hip fracture in the United States: A secondary analysis of administrative data.
Kumar A; Rahman M; Trivedi AN; Resnik L; Gozalo P; Mor V
PLoS Med; 2018 Jun; 15(6):e1002592. PubMed ID: 29944655
[TBL] [Abstract][Full Text] [Related]
11. Do Medicare Advantage Rebates Reduce Enrollees' Out-of-Pocket Spending?
Nicholas LH; Wu S
Med Care Res Rev; 2020 Oct; 77(5):474-482. PubMed ID: 30382801
[TBL] [Abstract][Full Text] [Related]
12. Association Between Care Management and Outcomes Among Patients With Complex Needs in Medicare Accountable Care Organizations.
Ouayogodé MH; Mainor AJ; Meara E; Bynum JPW; Colla CH
JAMA Netw Open; 2019 Jul; 2(7):e196939. PubMed ID: 31298714
[TBL] [Abstract][Full Text] [Related]
13. The Beneficial Effects Of Medicare Advantage Special Needs Plans For Patients With End-Stage Renal Disease.
Powers BW; Yan J; Zhu J; Linn KA; Jain SH; Kowalski J; Navathe AS
Health Aff (Millwood); 2020 Sep; 39(9):1486-1494. PubMed ID: 32897788
[TBL] [Abstract][Full Text] [Related]
14. Use of Data-Driven Methods to Predict Long-term Patterns of Health Care Spending for Medicare Patients.
Lauffenburger JC; Mahesri M; Choudhry NK
JAMA Netw Open; 2020 Oct; 3(10):e2020291. PubMed ID: 33074324
[TBL] [Abstract][Full Text] [Related]
15. Continuity of Care and Health Care Utilization in Older Adults With Dementia in Fee-for-Service Medicare.
Amjad H; Carmichael D; Austin AM; Chang CH; Bynum JP
JAMA Intern Med; 2016 Sep; 176(9):1371-8. PubMed ID: 27454945
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the use of the top-ranked cancer hospitals between Medicare Advantage and traditional Medicare.
Kim D; Meyers DJ; Rahman M; Trivedi AN
Am J Manag Care; 2021 Oct; 27(10):e355-e360. PubMed ID: 34668678
[TBL] [Abstract][Full Text] [Related]
17. Nonoperative care to manage sacroiliac joint disruption and degenerative sacroiliitis: high costs and medical resource utilization in the United States Medicare population.
Ackerman SJ; Polly DW; Knight T; Holt T; Cummings J
J Neurosurg Spine; 2014 Apr; 20(4):354-63. PubMed ID: 24527824
[TBL] [Abstract][Full Text] [Related]
18. Defining the 90-day cost structure of lower extremity revascularization for alternative payment model assessment.
Duwayri YM; Aiello FA; Tracci MC; Nedza S; Ryan PC; Adams JG; Shutze WP; Lum YW; Woo K
J Vasc Surg; 2021 Feb; 73(2):662-673.e3. PubMed ID: 32652115
[TBL] [Abstract][Full Text] [Related]
19. Segmenting high-cost Medicare patients into potentially actionable cohorts.
Joynt KE; Figueroa JF; Beaulieu N; Wild RC; Orav EJ; Jha AK
Healthc (Amst); 2017 Mar; 5(1-2):62-67. PubMed ID: 27914968
[TBL] [Abstract][Full Text] [Related]
20. Association Between Medicare Expenditure Growth and Mortality Rates in Patients With Acute Myocardial Infarction: A Comparison From 1999 Through 2014.
Likosky DS; Van Parys J; Zhou W; Borden WB; Weinstein MC; Skinner JS
JAMA Cardiol; 2018 Feb; 3(2):114-122. PubMed ID: 29261829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
